ESR1 and breast cancer: All breast cancer subtypes exhibit similar increases in age-specific incidence rates in premenopausal settings, while only ER-positive/PR-positive and ER-positive/PR-negative subtypes maintain increased age-specific incidence rates in postmenopausal settings [124].